ASPG and pancreatitis: Asparaginase-associated pancreatitis (AAP) has a reported incidence of 2 to 18% depending on the cumulative asparaginase dose (that is, treatment duration) and toxicity capture strategies but seemingly not on the route of administration7,158,169–174.